Alphatec Holdings, Inc.
ATEC
NASDAQ·Healthcare·Medical - Devices·Mkt cap $1.5B
$9.45
▲ +1.29%
P/E
-13.13
Mkt Cap
$1.5B
52-Wk Range
$6.82–$23.29
52-Week Range
$6.82 - $23.29
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 42.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- SafeOp Neural InformatiX platform reduces intraoperative nerve injury risk, differentiating from competitors
- Comprehensive product portfolio addressing multiple surgical approaches and pathologies
- Established distribution network and surgeon relationships built over 30+ years
- Proprietary minimally invasive surgical technologies (MIS SingleStep System)
- Integrated biologics offerings complementing hardware solutions
Bear Case
2 risks
- Average volatility.
- Premium valuation to Medical Devices peers
Growth
Turning profitable
Aging population increasing demand for spinal surgery procedures
Value
Premium valuation to Medical Devices peers
Momentum
Strong
+19.5% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying ATEC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 29, 2026
AUG 4, 2026
Reported EPS of $0.07 vs $0.07 consensus (0.0% surprise). Revenue of $213.5M vs $211.3M expected (+1.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
0.0%
Revenue trend · last 8Q
—
+28%
+22%
+27%
+30%
+20%
+14%
-204%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$150.7M
$176.8M
$169.2M
$185.5M
$196.5M
$212.9M
$192.1M
-$192.1M
Margins · last 8Q
Gross
-80.2%
Operating
1.0%
Profit
—
Wall Street consensus
11 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BMO Capital · Aug 5, 2026
vs Industry
How ATEC stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related